Sprycel Drug Analysis - CML & ALL - ResearchAndMarkets.com

DUBLIN--()--The "Drug analysis: Sprycel" drug pipelines has been added to ResearchAndMarkets.com's offering.

Sprycel (dasatinib; Bristol-Myers Squibb/Otsuka) is an oral targeted therapy that inhibits several tyrosine kinases including BCR-ABL, c-KIT, and the Src family kinases. The BCR-ABL fusion gene activates a number of signaling pathways that facilitate cancer cell transformation and proliferation, the inhibition of apoptosis, and adhesion and cytoskeleton abnormalities, all of which are characteristics of the disease. The presence of this gene is a result of the Philadelphia chromosome translocation, which is found in over 90% of chronic myeloid leukemia (CML) cases.

Key Topics Covered:

Product Profiles

Sprycel: Chronic myeloid leukemia (CML)

Sprycel: Acute lymphoblastic leukemia (ALL)

List of Figures

Figure 1: Sprycel for CML - SWOT analysis

Figure 2: Drug assessment summary of Sprycel for CML

Figure 3: Drug assessment summary of Sprycel for CML

Figure 4: Sprycel - SWOT analysis in acute lymphoblastic leukemia

Figure 5: Drug assessment summary for Sprycel in acute lymphoblastic leukemia

List of Tables

Table 1: Sprycel drug profile

Table 2: Sprycel pivotal trial data in CML

Table 3: Sprycel ongoing late-phase trial in CML

Table 4: Sprycel and Tasigna trial data in first-line CML

Table 5: Sprycel drug profile

Table 6: Overview of pivotal trial data for Sprycel in acute lymphoblastic leukemia

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/tg7ljm/sprycel_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Leukemia Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Leukemia Drugs